Atopic Dermatitis (AD) Epidemiology Analysis and Forecast to 2033
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Atopic Dermatitis (AD) Report Overview
In the 7MM, there were 42,015,612 diagnosed prevalent cases of AD in 2023. The diagnosed prevalent cases of AD will register an AGR of less than 1% during 2023-2033. Atopic dermatitis (AD) is a heterogenous and chronic inflammatory skin condition characterized by the remission and relapse of skin lesions and pruritus. Severe AD can impact patients’ daily life and cause sleep disturbances, anxiety, depression, and impaired quality of life.
Atopic Dermatitis (AD) Market Outlook, 2023-2033 (Diagnosed Prevalent Cases)
Buy the Full Report for More Insights into the Atopic Dermatitis (AD) Market Forecast
The atopic dermatitis (AD) market research report provides an overview of the severity and the global and historical epidemiological trends for AD in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). The report includes a 10-year epidemiology forecast for the 12-month diagnosed prevalent cases of AD.
| Market Size (2023) | 42,015,612 Cases |
| AGR (2023-2033) | <1% |
| Forecast Period | 2023-2033 |
| Key Countries | · The US
· France · Germany · Spain · Italy · The UK · Japan |
| Key Sex Segments | · Men
· Women |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Atopic Dermatitis (AD) Market Segmentation by Country
The key countries across the 7MM are the US, France, Germany, Spain, Italy, the UK, and Japan. In 2023, the US accounted for the highest number of diagnosed prevalent cases of AD in the 7MM. The increase in the 12-month diagnosed prevalent cases of AD in the 7MM can be attributed to changes in the population demographics in the respective markets and an increased trend in prevalence.
Atopic Dermatitis (AD) Market Analysis by Country, 2023 (%)
Buy the Full Report for More Country Insights into the Atopic Dermatitis (AD) Market
Download a Free Report Sample
Atopic Dermatitis (AD) Market Segmentation by Sex Type
Based on sex, the market can be segmented into men and women. In the 7MM combined, 12-month diagnosed prevalent cases of AD were lower in men than women in 2023. Of the 7MM, Germany had the highest proportion of cases in women, while Italy had the lowest proportion in 2023.
Atopic Dermatitis (AD) Market Analysis by Sex Type, 2023 (%)
Buy the Full Report for More Sex Type Insights into the Atopic Dermatitis (AD) Market
Segments Covered in the Report
Atopic Dermatitis (AD) Country Outlook (Diagnosed Prevalent Cases)
- The US
- France
- Germany
- Spain
- Italy
- The UK
- Japan
Atopic Dermatitis (AD) Sex Outlook (Diagnosed Prevalent Cases)
- Men
- Women
Scope
This report provides an overview of the severity and the global and historical epidemiological trends for AD in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). The report includes a 10-year epidemiology forecast for the 12-month diagnosed prevalent cases of AD. The 12-month diagnosed prevalent cases of AD are segmented by age (all ages) and sex (men and women). The 12-month diagnosed prevalent cases of AD among men and women are segmented by the severity of disease (mild, moderate, and severe). This epidemiology forecast for AD is supported by data obtained from country-specific peer-reviewed articles and population-based studies. The forecast methodology was kept consistent across the 7MM to allow for a meaningful comparison of the forecast 12-month diagnosed prevalent cases of AD across these markets.
Reasons to Buy
The Atopic Dermatitis Epidemiology series will allow you to:
- Develop business strategies by understanding the trends shaping and driving the global atopic dermatitis markets.
- Quantify patient populations in the global atopic dermatitis markets to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for atopic dermatitis therapeutics in each of the markets covered.
- Understand the magnitude of the atopic dermatitis population by age, sex, and disease severity.
Table of Contents
Table
Figures
Frequently asked questions
-
How many diagnosed prevalent cases of AD were seen in the 7MM in 2023?
In 2023, there were 42,015,612 diagnosed prevalent cases of AD in the 7MM.
-
What will the growth rate of the AD market be during the forecast period?
The diagnosed prevalent cases of AD will register an AGR of less than 1% during 2023-2033.
-
Which was the leading country in the AD market in 2023?
In 2023, the US accounted for the highest number of diagnosed prevalent cases of AD in the 7MM.
-
Which was the leading sex type in the AD market in 2023?
In 2023, the number of diagnosed prevalent cases of AD was higher in women in the 7MM combined.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Atopic Dermatitis (Atopic Eczema) reports


